BeStock  
Stocks › Biotechnology › DSGN

Design Therapeutics DSGN

US equityMarket cap rank #3474Biotechnology
$11.69 −$0.28 (-2.34%)
Pre-market · Oct 8, 8:20 am ET · After hours $11.69 0.00%
Open$11.82
Prev close$11.97
Day range$11.58 – $12.06
Volume344.5K
Market cap$731.58M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-9.9x
CheapRich

Below its usual level · 32nd percentile, 5-year average -9.4x

Price / book3.6x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average 1.8x

#3922 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-31x-20x-10x1xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$12.54
Price vs. fair value-6.8%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.62 – 1.77 92% (pricier than usual) #3922 of 5317 (1 = cheapest)
PE -9.91 -7.47 -9.41 32% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$12.54
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on DSGN.

Leave a comment

Scroll to Top